Market Dynamics:
The blood plasma derivatives market is driven by the increasing prevalence of immune diseases and bleeding disorders. For instance, according to World Federation of Hemophilia, 1 in 10,000 male children worldwide are born with hemophilia. Moreover, increasing demand for therapeutic plasma products due to their high efficacy and safety is also fueling the market growth. Therapeutic plasma products offer standardized dosage and minimal risk of pathogen transmission as compared to whole blood derived products. Furthermore, growing aging population who are more susceptible to immune and bleeding disorders is another factor propelling the market growth. However, high cost of plasma derivative therapies and stringent regulatory framework for plasma collection centers hampers the market growth.

Key Takeaways

The Global Blood Plasma Derivatives Market Size is expected to witness high growth, exhibiting CAGR of 9.3% over the forecast period, due to increasing prevalence of rare bleeding and immunological disorders.

Read More: https://newsinsights123.blogspot.com/2023/12/albumin-is-fastest-growing-segment.html